105 related articles for article (PubMed ID: 435334)
1. High-performance liquid chromatographic separation and identification of epimeric 17-ketone impurities in commercial sample of dexamethasone sodium phosphate.
Juenge EC; Brower JF
J Pharm Sci; 1979 May; 68(5):551-4. PubMed ID: 435334
[TBL] [Abstract][Full Text] [Related]
2. Quantitative TLC determination of epimeric ratios of 16-methyl 17-ketone oxidation products of dexamethasone and related drugs.
Juenge EC; Flinn PE
J Pharm Sci; 1981 Apr; 70(4):415-9. PubMed ID: 7229955
[TBL] [Abstract][Full Text] [Related]
3. [Identification of the impurities in
Ma X; Jin L; Li Y; Zheng H; Wei Y
Se Pu; 2018 Mar; 36(3):268-277. PubMed ID: 30136505
[TBL] [Abstract][Full Text] [Related]
4. Analysis of drug contamination from parabens in theophylline olamine.
Juenge EC; Gurka DF; Kreienbaum MA
J Pharm Sci; 1981 Jun; 70(6):589-93. PubMed ID: 7252796
[TBL] [Abstract][Full Text] [Related]
5. Estimation of impurity profiles of drugs and related materials: part 19: theme with variations. Identification of impurities in 3-oxosteroids.
Görög S; Babják M; Balogh G; Brlik J; Dravecz F; Gazdag M; Horváth P; Laukó A; Varga K
J Pharm Biomed Anal; 1998 Dec; 18(4-5):511-25. PubMed ID: 9919951
[TBL] [Abstract][Full Text] [Related]
6. Estimation of impurity profiles of drugs and related materials. 12. Isolation and identification of an isomeric impurity in danazol.
Balogh G; Csizér E; Ferenczy GG; Halmos Z; Herényi B; Horváth P; Laukó A; Görög S
Pharm Res; 1995 Feb; 12(2):295-8. PubMed ID: 7784348
[TBL] [Abstract][Full Text] [Related]
7. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
8. [Dexamethasone Sodium Phosphate Reference Standard (Control 001) of National Institute of Health Sciences].
Iwata M; Koide T; Maekawa K; Saito H; Tanimoto T; Okada S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2001; (119):89-92. PubMed ID: 11915294
[TBL] [Abstract][Full Text] [Related]
9. [Separation and identification of impurities in mifepristone].
Wu XJ; Song YW
Yao Xue Xue Bao; 1992; 27(10):796-9. PubMed ID: 1293931
[TBL] [Abstract][Full Text] [Related]
10. Determination of dexamethasone in milk by high pressure liquid chromatography.
DePaolis AM; Schnabel G; Katz SE; Rosen JD
J Assoc Off Anal Chem; 1977 Jan; 60(1):210-2. PubMed ID: 833098
[TBL] [Abstract][Full Text] [Related]
11. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
Görög S
Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of potential impurities of rabeprazole sodium.
Reddy GM; Bhaskar BV; Reddy PP; Sudhakar P; Babu JM; Vyas K; Reddy PR; Mukkanti K
J Pharm Biomed Anal; 2007 Mar; 43(4):1262-9. PubMed ID: 17134865
[TBL] [Abstract][Full Text] [Related]
13. Separation and identification of some common isomeric plant triterpenoids by thin-layer chromatography and high-performance liquid chromatography.
Martelanc M; Vovk I; Simonovska B
J Chromatogr A; 2009 Sep; 1216(38):6662-70. PubMed ID: 19695573
[TBL] [Abstract][Full Text] [Related]
14. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
[TBL] [Abstract][Full Text] [Related]
15. Stability-indicating chromatographic methods for determination of flecainide acetate in the presence of its degradation products; isolation and identification of two of its impurities.
El-Ragehy NA; Hassan NY; Tantawy MA; Abdelkawy M
Biomed Chromatogr; 2016 Oct; 30(10):1541-8. PubMed ID: 26992079
[TBL] [Abstract][Full Text] [Related]
16. [Identification of impurity peaks in the HPLC chromatogram by LC-MS and two-dimensional chromatographic correlation spectroscopy].
Chen ZZ; Zhang DS; Wang N; Feng F; Hu CQ
Yao Xue Xue Bao; 2012 Apr; 47(4):492-7. PubMed ID: 22799032
[TBL] [Abstract][Full Text] [Related]
17. Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matrices.
Görög S; Bihari M; Csizér E; Dravetz F; Gazdag M; Herényi B
J Pharm Biomed Anal; 1995 Dec; 14(1-2):85-92. PubMed ID: 8833970
[TBL] [Abstract][Full Text] [Related]
18. Structural identification and characterization of potential impurities of pantoprazole sodium.
Reddy GM; Bhaskar BV; Reddy PP; Ashok S; Sudhakar P; Babu JM; Vyas K; Mukkanti K
J Pharm Biomed Anal; 2007 Oct; 45(2):201-10. PubMed ID: 17629653
[TBL] [Abstract][Full Text] [Related]
19. Identification, characterization and synthesis of impurities of zafirlukast.
Goverdhan G; Reddy AR; Srinivas K; Himabindu V; Reddy GM
J Pharm Biomed Anal; 2009 May; 49(4):895-900. PubMed ID: 19231127
[TBL] [Abstract][Full Text] [Related]
20. Liquid chromatographic determination and identification tests for dexamethasone in bulk drugs and elixirs: collaborative study.
Bunch EA
J Assoc Off Anal Chem; 1987; 70(6):967-73. PubMed ID: 3436910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
